Report ID: SQMIG30C2143
Report ID:
SQMIG30C2143 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
99 |
Figures:
68
In 2022, North America emerged as the powerhouse of the cannabis testing market, commanding an impressive 84.6% revenue share and poised for sustained growth with a significant CAGR projected for the forecast period. A key driving force behind this expansion is the proliferation of testing laboratories, a direct response to stringent governmental regulations governing marijuana cultivation practices in the region.
The Asia Pacific anticipates a remarkable CAGR of 25.9% in the cannabis testing market, indicative of a substantial surge. This growth surge is propelled by the escalating trend of legalizing medical cannabis across multiple countries in the region. As legalization gains momentum, the demand for cannabis testing services is expected to soar, driven by governmental bodies and businesses prioritizing the assurance of safety and efficacy in medical cannabis products. This heightened emphasis on rigorous testing underscores the critical role these services play in ensuring the quality and reliability of medical cannabis offerings.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG30C2143